Signaturefd LLC Has $499,000 Stock Holdings in Centene Co. (NYSE:CNC)

Signaturefd LLC decreased its position in Centene Co. (NYSE:CNC) by 22.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 8,236 shares of the company’s stock after selling 2,325 shares during the period. Signaturefd LLC’s holdings in Centene were worth $499,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the business. Stratos Wealth Partners LTD. grew its position in shares of Centene by 4.1% in the 4th quarter. Stratos Wealth Partners LTD. now owns 4,094 shares of the company’s stock valued at $248,000 after purchasing an additional 163 shares during the period. Capital Advisors Ltd. LLC increased its position in shares of Centene by 75.3% during the fourth quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock worth $25,000 after acquiring an additional 177 shares in the last quarter. Private Trust Co. NA raised its holdings in shares of Centene by 23.7% during the fourth quarter. Private Trust Co. NA now owns 956 shares of the company’s stock worth $58,000 after acquiring an additional 183 shares during the period. Howard Capital Management Inc. boosted its stake in Centene by 5.4% in the 4th quarter. Howard Capital Management Inc. now owns 3,591 shares of the company’s stock worth $218,000 after purchasing an additional 184 shares during the period. Finally, Intellectus Partners LLC increased its holdings in Centene by 2.8% during the 4th quarter. Intellectus Partners LLC now owns 7,224 shares of the company’s stock worth $438,000 after purchasing an additional 200 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Ratings Changes

Several research firms have recently weighed in on CNC. Robert W. Baird upped their price objective on Centene from $66.00 to $71.00 in a research report on Tuesday, February 4th. Truist Financial lowered their price objective on shares of Centene from $89.00 to $84.00 and set a “buy” rating on the stock in a report on Friday, December 13th. Argus cut shares of Centene from a “buy” rating to a “hold” rating in a research report on Thursday, February 6th. Barclays upped their target price on Centene from $91.00 to $93.00 and gave the stock an “overweight” rating in a report on Friday, December 13th. Finally, UBS Group raised Centene from a “neutral” rating to a “buy” rating and boosted their price target for the stock from $79.00 to $80.00 in a research report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $79.92.

Centene Stock Up 0.7 %

CNC opened at $59.62 on Friday. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.10 and a current ratio of 1.11. The stock has a fifty day moving average of $60.32 and a 200-day moving average of $63.41. Centene Co. has a fifty-two week low of $55.03 and a fifty-two week high of $80.59. The company has a market capitalization of $29.58 billion, a P/E ratio of 9.55, a P/E/G ratio of 0.80 and a beta of 0.40.

Centene (NYSE:CNC) last announced its earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.49 by $0.31. The firm had revenue of $40.81 billion for the quarter, compared to analyst estimates of $38.78 billion. Centene had a net margin of 2.03% and a return on equity of 13.85%. The business’s revenue was up 3.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.45 EPS. On average, equities analysts expect that Centene Co. will post 6.86 EPS for the current year.

About Centene

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.